I-Shanghai IVEN Pharmatech Engineering Co., Ltd. umhlinzeki wezinsizakalo zokukhiqiza imithi ohamba phambili, umemezele ukuhlanganyela kwawo e-CPhI Worldwide Barcelona 2023 kusukela ngo-Okthoba 24-26. Lo mcimbi uzoba seGran Via e-Barcelona, ​​eSpain.

Njengomunye wemibukiso emikhulu emhlabeni wonke yemboni yezemithi, i-CPhI Barcelona inikeza ithuba elibalulekile le-IVEN ukuze ibonise amakhono ayo esevisi aphelele.

"Sijabule kakhulu ukuxhuma nontanga yezimboni kanye nabalingani e-CPhI Barcelona kulo nyaka," kusho uNksz Michelle Wang, uMqondisi Wezokumaketha ku-IVEN. "Kuyinkundla ebalulekile ye-VEN ukukhombisa ubuchwepheshe bethu ezinsizeni Zomkhiqizi Wemishini Yezemithi kanye nenethiwekhi nabadlali kulo lonke uchungechunge lokuhlinzeka ngamakhemisi emhlabeni jikelele."

Itholakala eBooth NO. I-3S70 e-Hall 3, i-VENN izogqamisa iminikelo yayo ehlanganisiwe ehlanganisa izidakamizwa, umkhiqizo wezidakamizwa, ukupakishwa, ukuhlolwa kokuhlaziya, kanyeamasevisi turnkey. Ngezindawo ezithuthukile e-China, i-VENN ihlinzeka ngezixazululo ezikhethekile ze-AZ turnkey zesitshalo semithi.

Ithimba le-IVEN lochwepheshe bezimboni lizobe likhona ukuze lixoxe ngamathuba obambiswano nokuthi izinsiza ze-IVEN zingangeza kanjani inani ezinkampanini ezithaka imithi emhlabeni wonke. Izivakashi zikhuthazwa ukuthi zivakashele idokodo le-IVEN ngezikhathi zombukiso kusukela ngo-9am kuya ku-6pm kusukela ngo-Okthoba 24-26.

Mayelana ne-VEN

I-IVEN eyasungulwa ngo-2005 futhi yalinywa ngokujulile emkhakheni wemboni yezemithi nezokwelapha, sasungula izitshalo ezine ezenza imishini yokugcwalisa nokupakisha imithi, uhlelo lokwelapha amanzi emithi, uhlelo lokudlulisa oluhlakaniphile kanye nelokusebenza. sinikeze izinkulungwane zemishini yokukhiqiza imithi nezokwelapha kanye namaphrojekthi we-turnkey, sanikeza amakhasimende amakhulu avela emazweni angaphezu kuka-50, sasiza amakhasimende ethu ukuthuthukisa ikhono lawo lokukhiqiza imithi nezokwelapha, awine isabelo semakethe kanye negama elihle emakethe yawo. Ukuze uthole ulwazi olwengeziwe, vakashela:www.iven-pharma.com